Mannino; Anthony

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mannino; Anthony.The latest application filed is for "processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds".

Company Profile

2.11.12

Mannino; Anthony - Maryland Heights MO
Mannino; Anthony - Lombard IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Processes For Preparing Morphinan-6-one Products With Low Levels Of Alpha, Beta-unsaturated Ketone Compounds App 20220079938 - Buehler; Henry J. ; et al.	2022-03-17
PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF a, -UNSATURATED KETONE COMPOUNDS App 20200338068 - Buehler; Henry J. ; et al.	2020-10-29
PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF a, -UNSATURATED KETONE COMPOUNDS App 20190381033 - Buehler; Henry J. ; et al.	2019-12-19
Processes For Preparing Morphinan-6-One Products With Low Levels Of Alpha, Beta-Unsaturated Ketone Compounds App 20180008596 - Buehler; Henry J ; et al.	2018-01-11
Processes For Preparing Morphinan-6-One Products With Low Levels Of Alpha, Beta-Unsaturated Ketone Compounds App 20160243113 - Buehler; Henry J. ; et al.	2016-08-25
Processes For Preparing Morphinan-6-One Products With Low Levels Of Alpha, Beta-Unsaturated Ketone Compounds App 20150148365 - Buehler; Henry J. ; et al.	2015-05-28
Use of oripavine as a starting material for buprenorphine Grant 8,993,764 - Mannino , et al. March 31, 2	2015-03-31
Process for preparing morphinan-6-one products with low levels of .alpha.,.beta.-unsaturated ketone compounds Grant 8,871,779 - Buehler , et al. October 28, 2	2014-10-28
Processes for preparing morphinan-6-one products with low levels of alpha beta-unsaturated compounds Grant 8,748,611 - Buehler , et al. June 10, 2	2014-06-10
Crystalline and amorphous forms of naltrexone hydrochloride Grant 8,399,475 - Nichols , et al. March 19, 2	2013-03-19
Processes for synthesis of opiate alkaloid derivatives Grant 8,273,887 - Mannino , et al. September 25, 2	2012-09-25
Processes for the production of buprenorphine with reduced impurity formation Grant 8,232,397 - Allen , et al. July 31, 2	2012-07-31
Processes For Preparing Morphinan-6-one Products With Low Levels Of Alpha Beta-unsaturated Compounds App 20120059167 - Buehler; Henry J. ; et al.	2012-03-08
Crystalline and Amorphous Forms of Naltrexone Hydrochloride App 20100120814 - Nichols; Gary A. ; et al.	2010-05-13
Processes for the production of buprenorphine with reduced impurity formation App 20100087647 - Allen; Brenda E. ; et al.	2010-04-08
Processes for synthesis of opiate alkaloid derivatives App 20100081816 - Mannino; Anthony ; et al.	2010-04-01
Use of Oripavine as a Starting Material For Buprenorphine App 20080312441 - Mannino; Anthony ; et al.	2008-12-18
Process for Preparing Morphinan-6-One Products with Low Levels of Alpha, Beta-Unsaturated Ketone Compounds App 20080312442 - Buehler; Henry J. ; et al.	2008-12-18
Split ring closure for cylindrical drum Grant 5,971,190 - Mannino October 26, 1	1999-10-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.